Bhatt DL - Search Results

1

Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.

Helton TJ, Bavry AA, Kumbhani DJ, Duggal S, Roukoz H, Bhatt DL. Helton TJ, et al. Among authors: bhatt dl. Am J Cardiovasc Drugs. 2007;7(4):289-97. doi: 10.2165/00129784-200707040-00006. Am J Cardiovasc Drugs. 2007. PMID: 17696569

2

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.

Marso SP, Lincoff AM, Ellis SG, Bhatt DL, Tanguay JF, Kleiman NS, Hammoud T, Booth JE, Sapp SK, Topol EJ. Marso SP, et al. Among authors: bhatt dl. Circulation. 1999 Dec 21-28;100(25):2477-84. doi: 10.1161/01.cir.100.25.2477. Circulation. 1999. PMID: 10604884 Clinical Trial.

3

Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease.

Bhatt DL, Topol EJ. Bhatt DL, et al. Med Clin North Am. 2000 Jan;84(1):163-79, ix. doi: 10.1016/s0025-7125(05)70212-1. Med Clin North Am. 2000. PMID: 10685133 Review.

4

Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators.

Bhatt DL, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Bhatt DL, et al. Am Heart J. 2000 Jul;140(1):67-73. doi: 10.1067/mhj.2000.108239. Am Heart J. 2000. PMID: 10874265 Clinical Trial.

5

Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.

Bhatt DL, Kapadia SR, Yadav JS, Topol EJ. Bhatt DL, et al. Cerebrovasc Dis. 2000;10 Suppl 5:34-40. doi: 10.1159/000047602. Cerebrovasc Dis. 2000. PMID: 11096181 Review.

6

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.

Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Bhatt DL, et al. Circulation. 2001 Jan 23;103(3):363-8. doi: 10.1161/01.cir.103.3.363. Circulation. 2001. PMID: 11157686 Clinical Trial.

7

Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.

Chew DP, Bhatt DL, Lincoff AM, Moliterno DJ, Brener SJ, Wolski KE, Topol EJ. Chew DP, et al. Among authors: bhatt dl. Circulation. 2001 Feb 20;103(7):961-6. doi: 10.1161/01.cir.103.7.961. Circulation. 2001. PMID: 11181470

8

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials.

Chew DP, Bhatt DL, Sapp S, Topol EJ. Chew DP, et al. Among authors: bhatt dl. Circulation. 2001 Jan 16;103(2):201-6. doi: 10.1161/01.cir.103.2.201. Circulation. 2001. PMID: 11208677

9

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.

Chew DP, Bhatt DL, Robbins MA, Mukherjee D, Roffi M, Schneider JP, Topol EJ, Ellis SG. Chew DP, et al. Among authors: bhatt dl. Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6. Am J Cardiol. 2001. PMID: 11564394 No abstract available.

10

Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting.

Bhatt DL, Kapadia SR, Bajzer CT, Chew DP, Ziada KM, Mukherjee D, Roffi M, Topol EJ, Yadav JS. Bhatt DL, et al. J Invasive Cardiol. 2001 Dec;13(12):767-71. J Invasive Cardiol. 2001. PMID: 11731685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,183 results

Search Page

Filters